Next Article in Journal
Ficus umbellata Vahl. (Moraceae) Stem Bark Extracts Exert Antitumor Activities In Vitro and In Vivo
Next Article in Special Issue
EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Previous Article in Journal
Validation of Splicing Events in Transcriptome Sequencing Data
Previous Article in Special Issue
Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(6), 1108;

Epigenetic Strategies to Boost Cancer Immunotherapies

CNIO-Lilly Epigenetics Laboratory, Spanish National Cancer Research Center (CNIO), C/Melchor Fernández Almagro, 3. 28029 Madrid, Spain
Academic Editor: Nicoletta Sacchi
Received: 27 April 2017 / Revised: 18 May 2017 / Accepted: 19 May 2017 / Published: 23 May 2017
(This article belongs to the Special Issue Cancer Epigenetics)
Full-Text   |   PDF [1421 KB, uploaded 23 May 2017]   |  


Recently, immunotherapeutic approaches have shown impressive responses in a subset of cancer patients. However, the rate of success is low and a large percentage of treated patients do not experience clinical benefits. Therefore, additional strategies are needed to improve responses and select responsive patients. Emerging data suggest that epigenetic drugs can improve the responses to immunotherapy. Understanding the mechanisms of resistance to immunotherapy and the epigenetic events that take place during immune evasion is critical to providing a rational combined use of immunotherapies and epigenetic drugs. This review focuses in the epigenetic mechanisms involved in the responses to immunotherapy and how current drugs that target epigenetic regulators impact on them. View Full-Text
Keywords: immunotherapy; cancer; epigenetics immunotherapy; cancer; epigenetics

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Barrero, M.J. Epigenetic Strategies to Boost Cancer Immunotherapies. Int. J. Mol. Sci. 2017, 18, 1108.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top